🟢 RLAY is trading 4.1% up today, extending a multi-day rally following its $275M equity offering

RLAY is trading 4.1% up at $18.76, continuing a strong multi-day rally that began earlier in June.

• The upward move follows a recently announced $275 million public share offering priced at $12 per share.
• Investor sentiment remains high due to ongoing enthusiasm surrounding the company's clinical pipeline and recent investor outreach efforts.
• There are no fresh company-specific headlines as of June 25, 2026, suggesting the price action is driven by continued momentum.